PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer ; volume:138 ; number:2 ; day:20 ; month:2 ; year:2013 ; pages:457-466 ; date:4.2013
Breast cancer research and treatment ; 138, Heft 2 (20.2.2013), 457-466, 4.2013
- Urheber
-
Martín, Miguel
Prat, Aleix
Rodríguez-Lescure, Álvaro
Caballero, Rosalía
Ebbert, Mark T. W.
Munárriz, Blanca
Ruiz-Borrego, Manuel
Bastien, Roy R. L.
Crespo, Carmen
Davis, Carole
Rodríguez, César A.
López-Vega, José M.
Furió, Vicente
García, Ana M.
Casas, Maribel
Ellis, Matthew J.
Berry, Donald A.
Pitcher, Brandelyn N.
Harris, Lyndsay
Ruiz, Amparo
Winer, Eric
Hudis, Clifford
Stijleman, Inge J.
Tuck, David P.
Carrasco, Eva
Perou, Charles M.
Bernard, Philip S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-013-2416-2
- URN
-
urn:nbn:de:101:1-2019080201531137740905
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Martín, Miguel
- Prat, Aleix
- Rodríguez-Lescure, Álvaro
- Caballero, Rosalía
- Ebbert, Mark T. W.
- Munárriz, Blanca
- Ruiz-Borrego, Manuel
- Bastien, Roy R. L.
- Crespo, Carmen
- Davis, Carole
- Rodríguez, César A.
- López-Vega, José M.
- Furió, Vicente
- García, Ana M.
- Casas, Maribel
- Ellis, Matthew J.
- Berry, Donald A.
- Pitcher, Brandelyn N.
- Harris, Lyndsay
- Ruiz, Amparo
- Winer, Eric
- Hudis, Clifford
- Stijleman, Inge J.
- Tuck, David P.
- Carrasco, Eva
- Perou, Charles M.
- Bernard, Philip S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Severe skin toxicity due to weekly paclitaxel administration
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome
Preoperative MELD score as a predictor for post hemihepatectomy complications
Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Severe skin toxicity due to weekly paclitaxel administration
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome
Preoperative MELD score as a predictor for post hemihepatectomy complications
Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Severe skin toxicity due to weekly paclitaxel administration
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors
Maximum preimplantation monosyllabic score as predictor of cochlear implant outcome
Preoperative MELD score as a predictor for post hemihepatectomy complications
Prospective Randomized Study Comparing Concomitant Chemoradiotherapy Using Three Weekly Cisplatin and Biweekly 5-Fluorouracil versus Weekly Paclitaxel in Locally Advanced Carcinoma Cervix